Jesy Nelson observed as lawmakers deliberated over the mandatory screening of infants for a fatal muscle degenerative condition. The former member of the music group Little Mix has partnered with the Mirror to bring attention to her petition, signed by over 150,000 individuals, advocating for all newborns to undergo testing for spinal muscular atrophy (SMA). Jesy’s advocacy stems from the delayed diagnosis of her own twins, resulting in irreversible nerve damage and a prognosis of never being able to walk.
The Parliamentary discussion was prompted by Jesy’s petition, which calls for SMA testing in newborns to allow for timely administration of new treatments that can effectively cure the disease if initiated at birth. Before heading to Parliament, Jesy expressed gratitude for the support garnered for the petition, emphasizing the significance of the debate for the SMA community and future infants at risk.
Despite the availability of potential curative drugs, the UK National Screening Committee has not endorsed the £5 blood test for SMA within the NHS since 2018. Jesy and the Mirror are advocating for policy changes following the delayed diagnosis of her daughters, highlighting the urgent need for all babies to receive the necessary screening.
Amidst the debate, concerns were raised about the delayed start of an NHS pilot program in England to test most newborns at birth, leaving a significant number untested as part of a control group. The discussion also shed light on the disparities in SMA screening across different regions in England, potentially impacting the timely diagnosis of affected infants.
The devolved administration in Scotland has already committed to screening all babies for SMA, but decisions are pending in Wales and Northern Ireland, leaving thousands of newborns untested annually. The introduction of routine SMA screening at birth is crucial, as early diagnosis and treatment can offer affected infants the best chance at a healthy future.
Jesy’s efforts, along with advocacy from SMA UK’s chief executive and MPs, aim to ensure that all babies in the UK have equal access to SMA screening and life-changing treatments. The ongoing debate underscores the necessity of proactive measures to protect infants from the devastating effects of SMA and guarantee them a better quality of life.
